Appeal Seeks to Uphold $25M Talc Cancer Verdict
Connecticut residents with asbestos exposure concerns should note a pending appeal that could shape how talc-related mesothelioma claims are handled.
Updated on Nov. 2, 2026 in Cancer
Plaintiffs asked a Connecticut appellate court to uphold a $25 million verdict against Johnson & Johnson in an asbestos-containing talcum powder mesothelioma case. The brief was filed in the Connecticut Appellate Court, where the plaintiffs, Evan C. Plotkin and Martha Barry, argue the jury had ample evidence linking Johnson & Johnson's Baby Powder to their injuries.
Why it matters
The case centers on whether talc products containing asbestos can be linked to mesothelioma, a cancer of the lining of the lungs and other organs, and how liability carries across corporate successors. Its outcome will shape how similar talc-related cancer claims are handled in the state.
The record is a single appellate brief in one mesothelioma case, not a study. The plaintiffs argue the trial court properly limited testimony from a Johnson & Johnson expert and correctly instructed the jury on successor liability under Connecticut and New Jersey law.
The players
Johnson & Johnson
A multinational health care company with major pharmaceutical and consumer health businesses, including the Baby Powder product at the center of talc litigation.
The details
Plotkin allegedly was exposed to asbestos-containing talc products, and the plaintiffs contend the jury was shown enough proof that Johnson & Johnson's Baby Powder caused his injuries. The successor liability question asks whether a company that took over a predecessor's operations can be held responsible for that predecessor's products.
Timeline
The action was filed in September 2021.
Plaintiffs' appellate brief urging the court to uphold the judgment was reported on November 2, 2026.
Health Landscape
Mesothelioma is a rare cancer closely tied to asbestos exposure, and talc litigation has produced repeated large verdicts against Johnson & Johnson. Appellate rulings like this one shape how far those verdicts and the liability behind them can reach.
If you have a history of asbestos exposure or are concerned about mesothelioma symptoms such as persistent chest pain, shortness of breath, or unexplained weight loss, it is worth discussing with your doctor. Lawsuits like this one do not change medical guidance on screening or prevention.
The takeaway
Mesothelioma is strongly linked to asbestos exposure, and this case highlights how legal outcomes can turn on product history and corporate succession. If you have concerns about past asbestos exposure, a conversation with your physician is the right next step.
Further reading
For broader context on the disease at the heart of the case, see Cancer coverage on We are Healthy.
Source note: This article includes information reported by Harrismartin.
